Literature DB >> 21965422

Intrathecal synthesis of IgM measured after a first demyelinating event suggestive of multiple sclerosis is associated with subsequent MRI brain lesion accrual.

Laurence Durante1, Wafaa Zaaraoui, Audrey Rico, Lydie Crespy, Delphine Wybrecht, Anthony Faivre, Françoise Reuter, Irina Malikova, Gilbert Pommier, Sylviane Confort-Gouny, Patrick J Cozzone, Jean-Philippe Ranjeva, Jean Pelletier, Jose Boucraut, Bertrand Audoin.   

Abstract

BACKGROUND: Previous studies have demonstrated that intrathecal synthesis of IgM is observed in multiple sclerosis (MS) and correlates with a worse disease course. These results suggest that IgM participates in the formation of MS lesions.
OBJECTIVE: The aim of the present study was to assess the potential association between the level of intrathecal synthesis of IgM measured after a clinically isolated syndrome (CIS) and the subsequent formation of brain lesions.
METHODS: Fifty seven patients with a CIS and a high risk developing MS were enrolled in a longitudinal study. Examination of cerebrospinal fluid was performed after the CIS and included measures of intrathecal IgM and IgG synthesis. Patients were assessed with the same 1.5 Tesla magnetic resonance imaging (MRI) system at baseline and after a mean follow-up period of 49 months (range 36-60). Spearman Rank correlation was used to assess the potential correlations between levels of intrathecal immunoglobulin synthesis and MRI data.
RESULTS: The level of intrathecal IgM synthesis was correlated with the number of gadolinium-enhancing lesions at baseline (p = 0.01) and with accrual of brain lesions during the follow-up period (p = 0.02). By taking into account brain sub-regions, we demonstrated that the level of intrathecal IgM synthesis was only correlated with the increased number of lesions in the periventricular regions (p = 0.004). The level of intrathecal IgG synthesis was not correlated with any MRI data.
CONCLUSION: The present longitudinal study demonstrates that the level of intrathecal IgM synthesis measured after a CIS is associated with subsequent lesion accrual during the first years of MS. This result emphasizes the involvement of IgM in plaque formation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21965422     DOI: 10.1177/1352458511424589

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  7 in total

1.  Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor?

Authors:  Jessica Frau; Luisa Maria Villar; Claudia Sardu; Maria Antonietta Secci; Lucia Schirru; Diana Ferraro; Giancarlo Coghe; Lorena Lorefice; Giuseppe Fenu; Roberta Bedin; Patrizia Sola; Maria Giovanna Marrosu; Eleonora Cocco
Journal:  J Neurol       Date:  2017-12-22       Impact factor: 4.849

2.  Experimental laboratory biomarkers in multiple sclerosis.

Authors:  Borros Arneth; Jörg Kraus
Journal:  Wien Med Wochenschr       Date:  2022-03-07

3.  CSF parameters associated with early MRI activity in patients with MS.

Authors:  Ana Klein; Rebecca C Selter; Alexander Hapfelmeier; Achim Berthele; Bertram Müller-Myhsok; Viola Pongratz; Christiane Gasperi; Claus Zimmer; Mark Mühlau; Bernhard Hemmer
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-05-30

4.  Increased intrathecal neurofilament light and immunoglobulin M predict severe disability in relapsing-remitting multiple sclerosis.

Authors:  Igal Rosenstein; Sofia Rasch; Markus Axelsson; Lenka Novakova; Kaj Blennow; Henrik Zetterberg; Jan Lycke
Journal:  Front Immunol       Date:  2022-08-10       Impact factor: 8.786

5.  Predicting Aggressive Multiple Sclerosis With Intrathecal IgM Synthesis Among Patients With a Clinically Isolated Syndrome.

Authors:  Enric Monreal; Susana Sainz de la Maza; Lucienne Costa-Frossard; Paulette Walo-Delgado; Javier Zamora; José Ignacio Fernández-Velasco; Noelia Villarrubia; Mercedes Espiño; Daniel Lourido; Paloma Lapuente; Inmaculada Toboso; José Carlos Álvarez-Cermeño; Jaime Masjuan; Luisa María Villar
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-07-22

6.  Cerebrospinal Fluid IgM Levels in Association With Inflammatory Pathways in Multiple Sclerosis Patients.

Authors:  Roberta Magliozzi; Valentina Mazziotti; Luigi Montibeller; Anna I Pisani; Damiano Marastoni; Agnese Tamanti; Stefania Rossi; Francesco Crescenzo; Massimiliano Calabrese
Journal:  Front Cell Neurosci       Date:  2020-10-16       Impact factor: 5.505

7.  High Levels of Cerebrospinal Fluid Kappa Free Light Chains Relate to IgM Intrathecal Synthesis and Might Have Prognostic Implications in Relapsing Multiple Sclerosis.

Authors:  Jéssica Castillo-Villalba; Sara Gil-Perotín; Raquel Gasque-Rubio; Laura Cubas-Nuñez; Sara Carratalà-Boscà; Carmen Alcalá; Carlos Quintanilla-Bordás; Francisco Pérez-Miralles; Cristina Ferrer; Antonio Cañada Martínez; Jordi Tortosa; Luís Solís-Tarazona; Luisa Campos; Alberto Leivas; Begoña Laíz Marro; Bonaventura Casanova
Journal:  Front Immunol       Date:  2022-03-07       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.